Ramachandaram, A. et al. 2023. REAL-WORLD EVIDENCE FOR THE USE OF SGLT2 INHIBITORS IN PATIENTS WITH TYPE 2 DIABETES AT A MALAYSIAN TERTIARY CARE CENTRE. Journal of the ASEAN Federation of Endocrine Societies. 38, S3 (Nov. 2023), 52.